Histone H3.3 G34-mutant Diffuse Gliomas In Adults - PubMed

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

The characteristics of H3.3 G34-mutant gliomas in adults have yet to be specifically described. Thirty adults with H3.3 G34-mutant diffuse gliomas were retrospectively reviewed for clinical and pathologic information. Molecular profiling using next-generation sequencing was performed in 29 of the 30 H3.3 G34-mutant patients with 1 patient lacking available tumor samples, as well as 82 IDH/H3 wild-type adult diffuse glioma patients. The age at diagnosis of H3.3 G34-mutant diffuse gliomas was significantly younger than IDH/H3 wild-type gliomas (24 vs. 57 y, P<0.001). Overall, 19 of the 30 patients were diagnosed of glioblastoma with the primitive neuronal component, and 8 were glioblastoma. The molecular profiling analysis revealed higher frequencies of Olig-2 loss of expression, TP53 mutation, ATRX mutation, PDGFRA mutation, and MGMT promoter methylation (P<0.05) in H3.3 G34-mutant gliomas than IDH/H3 wild-type gliomas. No TERT promoter mutation and only 1 case of EGFR amplification were detected in the H3.3 G34-mutant cohort, the frequencies of which were significantly higher in the IDH/H3 wild-type cohort. A dismal prognosis was observed in H3.3 G34-mutant patients comparing to IDH/H3 wild-type cohort (overall survival: 14 vs. 22 mo; P=0.026). Univariate and multivariate analyses showed that the extent of resection and TP53 mutation were independently affecting prognosis. The distinct pathologic and molecular features of H3.3 G34-mutant diffuse gliomas in adult patients demonstrated the clinical importance of detecting H3.3 G34R/V mutations. The dismal prognosis of this rare high-grade glioma disease we reported here would further promote the investigation of dedicated therapeutic strategies.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest and Source of Funding: Supported by the Beijing Nova program (Z201100006820149), Beijing Higher Education Young Elite Teacher Project (CIT&TCD201904091) to L.W., and Beijing, Tianjin and Hebei Basic Research Cooperation Project (19JCZDJC64900(Z)) to L.T. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

References

1. 1. Wu G, Broniscer A, McEachron TA, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012;44:251–253.
2. 1. Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482:226–231.
3. 1. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803–820.
4. 1. Sturm D, Witt H, Hovestadt V, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell. 2012;22:425–437.
5. 1. Brat DJ, Aldape K, Colman H, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol. 2018;136:805–810.

Show all 27 references

Publication types

• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Adolescent Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Adult Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Biomarkers, Tumor / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain Neoplasms / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain Neoplasms / mortality Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain Neoplasms / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Brain Neoplasms / surgery Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Female Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Genetic Predisposition to Disease Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glioma / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glioma / mortality Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glioma / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glioma / surgery Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Histones / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Isocitrate Dehydrogenase / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Male Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Middle Aged Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mutation* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neoplasm Grading Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Phenotype Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Progression-Free Survival Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Retrospective Studies Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Risk Assessment Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Risk Factors Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Young Adult Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Biomarkers, Tumor Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Histones Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• IDH2 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Isocitrate Dehydrogenase Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• IDH1 protein, human Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • Ingenta plc
  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal